Papers
2
Total Citations
24
H-Index
2
About
Mehran Yusuf is a leading researcher in radiation oncology, with a focused expertise in stereotactic radiosurgery (SRS) for brain metastases. His work centers on optimizing treatment outcomes through precise dose-volume modeling and understanding the biological behavior of aggressive tumor histologies. Yusuf’s seminal 2016 study, cited 15 times, established a critical dose-volume response model for brain metastases treated with frameless single-fraction robotic radiosurgery. This work provided clinicians with a predictive framework to better anticipate local control, directly improving patient-specific treatment planning. Further demonstrating his impact, Yusuf investigated the interplay between radiosurgery fractionation and post-treatment hemorrhage in melanoma brain metastases (2022, 9 citations), a high-risk patient population. By identifying key predictors of adverse outcomes, his research has advanced safer, more effective SRS protocols. With a growing citation record, Yusuf’s contributions are shaping modern radiosurgical practice, offering both immediate clinical utility and a foundation for future studies in dose optimization and tumor-specific response.
Research Focus
Key Achievements
Top Papers
- 1
- 2